Drug Delivery & Nanomedicines

The development of effective drug delivery systems requires more than selecting a carrier. Cargo properties, carrier composition, molecular interactions, biological barriers and intracellular trafficking can all influence whether a delivery system performs as intended.

At Peptide Intelligence Consulting, we help researchers and R&D teams investigate these factors and develop informed strategies for peptide-enabled delivery, lipid-based nanomedicine and responsive molecular systems.

Our approach connects peptide chemistry, membrane interactions, nanocarrier design and scientific characterization to support evidence-based decisions during early-stage research and development.

Understand → Analyse → Design → Evaluate

We begin by defining the delivery objective, cargo requirements and main scientific challenge. We then examine the molecular interactions, carrier properties and biological barriers relevant to the system.

Based on this assessment, we identify testable hypotheses, recommend appropriate characterization methods and develop a strategy for evaluating candidate formulations or delivery mechanisms.

The work is tailored to the project, with a focus on distinguishing promising design concepts from experimentally demonstrated performance.

Why Peptide Intelligence Consulting?

Molecular-level insight

We consider how peptide sequence, charge, hydrophobicity and conformation can influence interactions with carriers, membranes and biological environments.

An integrated delivery perspective

We connect carrier design with membrane interactions, intracellular trafficking and functional cargo delivery rather than treating particle formation as the final outcome.

Evidence-guided evaluation

We help identify what existing data demonstrate, where uncertainties remain and which experiments can best address them.

Application-oriented strategies

We tailor design and evaluation recommendations to the cargo, delivery objective, available evidence and stage of research.